Recombinant Mouse Gap junction gamma-1 protein (Gjc1)

Basic Research Questions

• What is mouse Gjc1 and how does it compare to human GJC1?

Mouse Gjc1 (also known as Connexin-45 or Cx45) is a gap junction protein that forms intercellular channels allowing the diffusion of small molecules between adjacent cells. The mouse ortholog shares significant homology with human GJC1 (also called GJA7/Cx45).

The human GJC1 protein is encoded by the GJC1 gene, a member of the connexin gene family. It functions as a component of gap junctions, which provide routes for diffusion of low molecular weight materials (below 1-1.5 kDa) between cells, including ions, second messengers, amino acids, and metabolites .

Mouse Gjc1 (UniProt ID: P28229) and human GJC1 (UniProt ID: P36383) share conserved functional domains, particularly in the transmembrane and extracellular loop regions critical for channel formation . Both proteins contain four transmembrane domains with similar topology and are involved in cardiac function .

• What are the optimal conditions for handling recombinant mouse Gjc1 protein?

For optimal handling of recombinant mouse Gjc1 protein:

• Storage: Store at -20°C/-80°C. The shelf life is typically 6 months for liquid formulations and 12 months for lyophilized forms at these temperatures .

• Reconstitution: Briefly centrifuge before opening to bring contents to the bottom. Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C .

• Stability: Repeated freezing and thawing is not recommended. Working aliquots can be stored at 4°C for up to one week .

• Purity considerations: Commercially available recombinant proteins typically have >85% purity as verified by SDS-PAGE .

• How can I verify the expression and localization of Gjc1 in mouse tissue samples?

To verify Gjc1 expression and localization in mouse tissue samples:

Immunohistochemistry/Immunofluorescence approach:

• Fix tissue samples with 4% paraformaldehyde or 80% methanol (5 minutes).

• Permeabilize with 0.1% PBS-Tween for 20 minutes.

• Block with PBS containing 10% normal serum and 0.3M glycine to reduce non-specific interactions.

• Incubate with primary antibodies specific to Gjc1/Cx45 (such as monoclonal antibodies) at appropriate concentrations (typically 1μg/1×10^6 cells) for 30 minutes at room temperature .

• Apply fluorophore-conjugated secondary antibodies (e.g., DyLight® 488) at 1/500 dilution for 30 minutes.

• Include appropriate isotype controls to verify specificity .

Co-localization studies:
Gjc1 often co-localizes with other connexins such as Gja1 (Cx43) at intercalated discs in cardiac tissue. Double immunostaining can reveal these interactions as shown in studies of human cardiac tissue .

• What is the molecular structure of mouse Gjc1 and how does this influence its function?

Mouse Gjc1 is a 396 amino acid transmembrane protein with the following structural features:

• Domains: Contains four transmembrane domains that anchor the protein in the cell membrane .

• Topology: Features two extracellular loops that are critical for docking with connexins in adjacent cells and one cytoplasmic loop.

• Functional elements: The N-terminal and C-terminal regions face the cytoplasm and contain regulatory sites for post-translational modifications.

The protein's structure directly influences its function in several ways:

• Channel formation: Six connexin proteins assemble to form a connexon (hemichannel). When aligned with a connexon from an adjacent cell, they create a complete gap junction channel .

• Selectivity and permeability: The pore size and amino acid composition determine which molecules can pass through the channel. Gjc1 channels typically allow passage of molecules up to 1-1.5 kDa, including ions (K+, Ca2+) and second messengers (IP3, cAMP) .

• Regulation: The cytoplasmic domains contain sites for phosphorylation and other post-translational modifications that regulate channel opening, closing, and degradation .

Advanced Research Questions

• How can I design experiments to investigate Gjc1 mutations associated with cardiac diseases?

To investigate Gjc1 mutations associated with cardiac diseases:

Step 1: Mutation identification and analysis

• Conduct bioinformatic analysis of known Gjc1/GJC1 mutations using databases like ClinVar or gnomAD.

• Apply domain distribution analysis to locate mutations in specific protein regions (transmembrane, extracellular loops, cytoplasmic regions) .

• Utilize conservation analysis across species to identify critical residues .

Step 2: Functional characterization approaches

• Site-directed mutagenesis: Generate recombinant mouse Gjc1 constructs with disease-associated mutations.

• Electrophysiological analysis:

  • Dual whole-cell patch-clamp to measure gap junction conductance

  • Dye transfer assays to assess channel permeability to different molecules

  • These approaches have successfully characterized mutations in related connexins (GJA5/Cx40) associated with atrial fibrillation .

Step 3: In vivo models

• Generate transgenic or knock-in mouse models expressing Gjc1 mutations.

• Assess cardiac conduction using:

  • Electrocardiography (ECG)

  • Optical mapping

  • Intracardiac electrophysiology studies

Step 4: Molecular analyses

• Examine protein trafficking using immunohistochemistry and confocal microscopy.

• Assess protein-protein interactions with co-immunoprecipitation and proximity ligation assays.

• Evaluate channel assembly using biochemical approaches like sucrose gradient centrifugation.

Studies of GJA1 (Cx43) mutations provide a methodological template, as shown in research on oculodentodigital dysplasia where mutations disrupt gap junction function through various mechanisms .

• What techniques are most effective for studying heterotypic interactions between Gjc1 and other connexins?

For studying heterotypic interactions between Gjc1 and other connexins:

Cell-based systems:

• Co-expression systems: Transfect cells with Gjc1 and another connexin (e.g., Cx43) in separate populations, then co-culture to allow formation of heterotypic channels .

• Engineered connexin variants: Create chimeric or mutant connexins to identify critical residues for docking and channel function, as demonstrated in studies of Cx26/Cx43 heterotypic channels .

Functional assays:

• Dual whole-cell patch clamp: Measure electrical coupling between cells expressing different connexins.

• Dye transfer selectivity: Use gap junction-permeable dyes of different sizes and charges to evaluate permeability characteristics:

  • Lucifer Yellow (MW 457 Da, -2 charge)

  • Neurobiotin (MW 323 Da, +1 charge)

  • Propidium iodide (MW 668 Da, +2 charge)

Molecular docking analyses:

• Structure-based analysis: Use homology modeling and molecular dynamics simulations to predict docking interfaces, as has been done with Cx32/Cx26 interactions where asparagine 175 was identified as a critical residue for heterotypic docking .

• Mutagenesis validation: Test predictions by mutating specific residues in the extracellular loops.

Research has shown that specific extracellular loop residues are crucial for compatibility between different connexins in heterotypic channels, with mutations potentially altering selectivity and conductance .

• How does Gjc1 function differ in various cardiac cell types and what methods best characterize these differences?

Gjc1 exhibits cell type-specific functions in the cardiac conduction system:

Cell type-specific expression patterns:

• Sinoatrial node (SAN): Gjc1 is highly expressed in mouse SAN cells, contributing to the unique electrophysiological properties of pacemaker cells.

• Atrioventricular node (AVN): Gjc1 expression is essential for proper conduction delay at the AVN.

• Working myocardium: Gjc1 is expressed at lower levels but forms heterotypic channels with Gja1 (Cx43).

Methods to characterize cell type-specific functions:

• Conditional knockout models: Using Cre-loxP system with cell type-specific promoters:

  • HCN4-CreERT2 for SAN-specific deletion

  • Tbx3-Cre for AVN-specific deletion

  • αMHC-Cre for working myocardium

• Electrophysiological approaches:

  • Isolated heart preparations with optical mapping

  • Patch clamp recordings from isolated cardiomyocytes

  • Multi-electrode arrays for field potential recordings

• Single-cell RNA sequencing: To characterize Gjc1 expression levels across cardiac cell populations.

• Cell type-specific proteomics: To identify Gjc1 interaction partners unique to each cardiac cell type.

Recent research has shown that GJC1 mutations can cause congenital heart disease and arrhythmias, mapping to chromosome 17q21.31-q21.33 in humans . A study demonstrated that GJB4 (another connexin) co-localizes with GJA1 in diseased hearts, suggesting complex connexin interactions in cardiac pathology .

• What are the most effective approaches for studying the phosphorylation status of Gjc1 and its impact on channel gating?

To study Gjc1 phosphorylation and its impact on channel gating:

Identification of phosphorylation sites:

• Mass spectrometry approaches:

  • Immunoprecipitate Gjc1 from mouse tissue/cells

  • Perform phosphoproteomic analysis using tandem mass spectrometry

  • Map identified phosphopeptides to the Gjc1 sequence

• Phospho-specific antibodies:

  • Develop antibodies against predicted phosphorylation sites

  • Validate using phosphatase treatments and site-directed mutagenesis

Functional characterization:

• Phosphomimetic mutants:

  • Replace phosphorylatable serine/threonine residues with aspartate/glutamate to mimic phosphorylation

  • Replace with alanine to prevent phosphorylation

  • Express in communication-deficient cell lines

• Electrophysiological assessment:

  • Single channel recordings to measure open probability and conductance states

  • Voltage-clamp studies to assess voltage-dependent gating

  • Determine changes in ionic selectivity

• Kinase/phosphatase manipulation:

  • Apply specific kinase activators or inhibitors (PKA, PKC, MAPK)

  • Use phosphatase inhibitors (okadaic acid, calyculin A)

  • Measure acute effects on channel function

Studies on other connexins have shown that phosphorylation can regulate trafficking, assembly, gating, and degradation. For example, Cx43 phosphorylation by casein kinase 1 promotes gap junction assembly, while PKC-mediated phosphorylation can decrease channel conductance . Similar approaches can be applied to Gjc1.

• How can I differentiate between hemichannel and gap junction activities when studying Gjc1 function?

Differentiating between hemichannel and gap junction activities of Gjc1 requires specific experimental approaches:

Hemichannel activity assessment:

• Low calcium conditions: Hemichannels open in low extracellular calcium (0.2 mM or below). Perform experiments in calcium-free medium to promote hemichannel opening.

• Dye uptake assays: Use membrane-impermeable fluorescent dyes that can enter cells via hemichannels:

  • Ethidium bromide (MW 394 Da)

  • Propidium iodide (MW 668 Da)

  • Measure fluorescence increase in individual cells over time

• Electrophysiological methods:

  • Whole-cell patch clamp to measure hemichannel currents

  • Use hemichannel blockers (carbenoxolone, La³⁺, flufenamic acid) to confirm specificity

Gap junction activity assessment:

• Dual cell patch clamp: Directly measure electrical coupling between adjacent cells

• Dye transfer assays: Inject tracer dyes into one cell and monitor spread to adjacent cells:

  • Microinjection of Lucifer Yellow

  • Scrape-loading technique

  • Gap-FRAP (Fluorescence Recovery After Photobleaching)

• Specific inhibitors: Use peptides mimicking connexin extracellular loops to block gap junction channels but not hemichannels

Controls to distinguish activities:

• Cell density manipulation: Hemichannel activity is observed in sparse cultures; gap junction activity requires cell-cell contact

• Connexin-mimetic peptides: Gap27 disrupts gap junctions but has delayed effects on hemichannels

Research on pannexins (which only form hemichannels, not gap junctions) has established that pannexins are glycoproteins with distinct characteristics from connexins, providing a useful comparative system .

• What are the most robust approaches for studying Gjc1 trafficking and life cycle in cardiomyocytes?

For studying Gjc1 trafficking and life cycle in cardiomyocytes:

Protein synthesis and trafficking:

• Pulse-chase experiments:

  • Label newly synthesized proteins with radioactive amino acids or click chemistry

  • Track their movement through cellular compartments over time

• Live-cell imaging:

  • Generate Gjc1-fluorescent protein fusions (GFP, mCherry)

  • Use RUSH system (Retention Using Selective Hooks) to synchronize protein release from ER

  • Perform time-lapse confocal microscopy to track movement

• Organelle markers:

  • Co-label with markers for ER (calnexin), Golgi (GM130), and plasma membrane

  • Quantify colocalization at different time points

Gap junction assembly and stability:

• FRAP (Fluorescence Recovery After Photobleaching):

  • Bleach Gjc1-GFP at gap junction plaques

  • Measure fluorescence recovery to determine mobile fraction and half-time

  • Compare wild-type vs. mutant proteins

• Triton solubility assays:

  • Extract cells with 1% Triton X-100

  • Gap junction plaques remain in insoluble fraction

  • Quantify distribution by Western blot

• Super-resolution microscopy:

  • STORM or PALM imaging to visualize gap junction assembly at nanoscale resolution

  • Track connexon arrangement within plaques

Degradation pathways:

• Inhibitor studies:

  • Lysosomal inhibitors (bafilomycin A1, chloroquine)

  • Proteasomal inhibitors (MG132, lactacystin)

  • Autophagy inhibitors (3-methyladenine)

• Ubiquitination analysis:

  • Immunoprecipitate Gjc1 and probe for ubiquitin

  • Use mass spectrometry to identify ubiquitination sites

Research on other connexins has demonstrated that connexin trafficking follows the conventional secretory pathway, with quality control in the ER, oligomerization in the ER/Golgi, and transport to the plasma membrane via microtubules. Gjc1 is likely to follow similar pathways with protein-specific variations .